Form 4: Carmell Corp Director Scott M. Frisch Reports Acquisition of Common Stock
SEC Filing
Director Scott M. Frisch reports acquiring 1,009 shares of Carmell Corp common stock at $0.51 per share through Carmell Insiders LLC.
Summary
- Scott M. Frisch, a director of Carmell Corp, filed a Form 4 disclosing a purchase of the company's common stock.
- On September 6, 2024, Frisch acquired 1,009 shares at a price of $0.51 per share.
- The shares were acquired indirectly through Carmell Insiders LLC, of which Frisch owns a 15.3% interest.
- The total amount invested in the LLC by its members was $130,750 as of the date of this filing.
- Following the transaction, Frisch beneficially owns 7,598 shares indirectly through the LLC and 20,821 shares directly through stock options exercisable within 60 days.
- The purpose of the LLC is to allow board members to acquire shares during periods when they don't possess material nonpublic information.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing simply reports a transaction. The purchase is a positive signal, but the amount is not substantial enough to significantly alter sentiment.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
- The LLC structure allows insiders to purchase shares in compliance with insider trading policies.
Risks
- The Form 4 filing itself doesn't inherently indicate risks, but it's important to monitor insider transactions for any unusual patterns or large-scale selling, which could signal concerns.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Purchases are generally viewed more favorably than sales.
Comparison to Industry Standards
- Comparing the size of this transaction to similar insider transactions in comparable companies within the biotech or medical device industry could provide context.
- For example, if other executives at similarly sized companies are making larger purchases, it might suggest that Frisch's purchase is relatively small.
- Conversely, if insider buying is rare in the industry, this transaction could be seen as more significant.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Date of common stock transaction |
| 09/10/2024 | Date of Form 4 filing |
Keywords
Form 4, insider trading, stock acquisition, Carmell Corp, CTCX, Scott M. Frisch, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.